Clinical Trial Update: A Study to Assess the Effectiveness of Trastuzumab Deruxtecan in Chinese Breast Cancer Patients (REFRESH)

View source ↗

Summary

Daiichi Sankyo is conducting a trial to evaluate the effectiveness of trastuzumab deruxtecan in Chinese patients with breast cancer, including HER2-positive and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Low Breast Cancer

Drugs mentioned

• Trastuzumab Deruxtecan (Enhertu) (trastuzumab deruxtecan)

Snippet

Sponsor: Daiichi Sankyo | Conditions: HER2-positive Breast Cancer, HER2-low Breast Cancer | Status: RECRUITING